🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
565,72 USD
Máx. histórico
608,49
1 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,03%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-7,03%
Cierre anterior
608,49
Rango de hoy
561,24 – 608,04
Volumen hoy
602.001
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,36 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 10 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 15/05/2013 | 68,40 | 68,91 | 67,43 | 67,86 | -0,57% | 2,16% | 560.300 |
| 14/05/2013 | 67,65 | 68,38 | 67,50 | 68,25 | +1,11% | 1,30% | 731.900 |
| 13/05/2013 | 66,51 | 68,05 | 66,35 | 67,50 | +1,38% | 2,56% | 575.600 |
| 10/05/2013 | 65,24 | 66,92 | 65,15 | 66,58 | +2,27% | 2,71% | 939.500 |
| 09/05/2013 | 65,15 | 65,35 | 64,37 | 65,10 | -0,46% | 1,50% | 353.600 |
| 08/05/2013 | 65,47 | 65,90 | 65,15 | 65,40 | -0,05% | 1,15% | 609.500 |
| 07/05/2013 | 65,83 | 65,87 | 65,24 | 65,43 | -0,64% | 0,96% | 768.200 |
| 06/05/2013 | 65,98 | 66,20 | 65,29 | 65,85 | +0,06% | 1,38% | 555.800 |
| 03/05/2013 | 67,66 | 67,75 | 65,65 | 65,81 | -2,02% | 3,10% | 878.100 |
| 02/05/2013 | 66,75 | 67,46 | 66,52 | 67,17 | +0,73% | 1,41% | 568.000 |
| 01/05/2013 | 66,78 | 67,00 | 65,79 | 66,68 | -0,15% | 1,81% | 998.800 |
| 30/04/2013 | 65,04 | 68,25 | 64,98 | 66,78 | +2,77% | 5,03% | 1.736.700 |
| 29/04/2013 | 62,55 | 65,42 | 62,29 | 64,98 | +4,47% | 5,00% | 1.262.900 |
| 26/04/2013 | 60,83 | 63,29 | 60,83 | 62,20 | +0,86% | 4,04% | 913.300 |
| 25/04/2013 | 59,05 | 61,86 | 59,05 | 61,67 | -2,45% | 4,76% | 1.966.500 |
| 24/04/2013 | 61,78 | 64,00 | 61,26 | 63,22 | +2,53% | 4,44% | 1.341.500 |
| 23/04/2013 | 61,70 | 62,46 | 61,15 | 61,66 | +0,82% | 2,12% | 771.200 |
| 22/04/2013 | 60,39 | 61,43 | 59,59 | 61,16 | +1,49% | 3,05% | 594.400 |
| 19/04/2013 | 59,87 | 60,42 | 59,44 | 60,26 | +0,99% | 1,64% | 615.700 |
| 18/04/2013 | 60,69 | 60,69 | 59,32 | 59,67 | -1,37% | 2,26% | 655.300 |
| 17/04/2013 | 60,83 | 60,93 | 59,50 | 60,50 | -0,95% | 2,35% | 816.600 |
| 16/04/2013 | 60,76 | 61,12 | 60,28 | 61,08 | +1,39% | 1,38% | 473.000 |
| 15/04/2013 | 61,42 | 61,61 | 59,97 | 60,24 | -2,32% | 2,67% | 627.800 |
| 12/04/2013 | 61,45 | 61,71 | 60,68 | 61,67 | +0,19% | 1,68% | 429.200 |
| 11/04/2013 | 61,20 | 61,77 | 61,00 | 61,55 | +0,47% | 1,26% | 594.000 |
| 10/04/2013 | 60,19 | 61,62 | 59,87 | 61,26 | +2,72% | 2,91% | 817.600 |
| 09/04/2013 | 60,08 | 60,12 | 59,52 | 59,64 | -0,40% | 1,00% | 919.400 |
| 08/04/2013 | 60,22 | 60,45 | 59,58 | 59,88 | -0,22% | 1,44% | 542.600 |
| 05/04/2013 | 59,32 | 60,03 | 59,02 | 60,01 | +0,00% | 1,70% | 688.900 |
| 04/04/2013 | 60,09 | 60,09 | 59,58 | 60,01 | +0,20% | 0,85% | 566.400 |